ATAC - Pharmacokinetics (PK) Sub-Protocol
NCT00784862 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9358
Last updated 2009-05-15
Summary
To assess the effect of ARIMIDEX on the pharmacokinetics of tamoxifen and the effects of tamoxifen on the pharmacokinetics of ARIMIDEX..
Conditions
Interventions
- DRUG
-
Anastrozole
1mg, orally, once daily
- DRUG
-
Tamoxifen
20mg, orally, once daily
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-06-30
- Completion
- 1999-03-31
More Related Trials
-
PROACT - Pre-Operative Arimidex Compared To Tamoxifen
NCT00232661 ·Status: COMPLETED ·Phase: PHASE3
-
ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
NCT00286117 ·Status: COMPLETED ·Phase: PHASE3
-
Second Line Breast Cancer Trial
NCT00635713 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
NCT00259090 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
NCT00562458 ·Status: COMPLETED
-
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
NCT00241449 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
NCT00038467 ·Status: COMPLETED ·Phase: PHASE3
-
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
NCT00002967 ·Status: COMPLETED ·Phase: PHASE3
-
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
NCT00291759 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
NCT00274469 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
NCT02093351 ·Status: COMPLETED ·Phase: PHASE1
-
Secondary Adjuvant Long Term Study With Arimidex
NCT00295620 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
NCT00309491 ·Status: COMPLETED ·Phase: PHASE3
-
Liver Safety Under Upfront Arimidex vs Tamoxifen
NCT00537771 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Arimidex in Gynecomastia
NCT00241436 ·Status: COMPLETED ·Phase: PHASE2
-
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
NCT00605267 ·Status: COMPLETED ·Phase: PHASE3
-
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
NCT00357110 ·Status: COMPLETED ·Phase: PHASE2
-
Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
NCT00638391 ·Status: COMPLETED
-
Tamoxifen in Treating Women With Breast Cancer
NCT00003678 ·Status: UNKNOWN ·Phase: PHASE3
-
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
NCT00570323 ·Status: COMPLETED ·Phase: PHASE2
-
Arimidex Observational: Reason for and Effect of Change From Tamoxifen
NCT00246961 ·Status: COMPLETED
-
Tamoxifen in Treating Women With High-Risk Breast Cancer
NCT00002542 ·Status: COMPLETED ·Phase: PHASE3
-
Breast Cancer Tumor Care Observational Programme
NCT00660244 ·Status: COMPLETED
-
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00003418 ·Status: UNKNOWN ·Phase: PHASE3